granted
on 30 May 2024
Last Applicant/ Owned by
3889 Maple Avenue, Suite 500
Dallas
TX
75219
Serial Number
97472735 filed on 23rd Jun 2022
Registration Number
N/A
Correspondent Address
Aaron Y. Silverstein Saunders & Silverstein LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research consulting services in the field of medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; scientific research services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, and oncologic data; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, biology, and pharmaceuticals; genetic mapping Read More
Consulting services in the field of healthcare; medical analysis services of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data relating to the treatment of persons; healthcare and medical services, namely, providing databases in the fields of genetic, oncological, and biological information for inputting, collecting, analyzing and managing scientific data for treatment and diagnostic purposes; healthcare services, namely, medical services in the nature of analyzing scientific genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing clinical medical consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods
11th 000101
11th 000101
Scientific research consulting services in the field of medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; scientific research services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, and oncologic data; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, biology, and pharmaceuticals; genetic mapping for scientific and medical purposes; providing medical and scientific research information in the fields of genetics, oncology, biology, and pharmaceuticals; drug discovery services; providing scientific, medical, and clinical research and scientific consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods; medical and scientific research and scientific consulting, namely, designing and supporting clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services using machine-learning algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer and other diseases; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations and medicines; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of cancer treatment and diagnosis
11th 000101
11th 000101
No 97472735
No Service Mark
No 1762.400.66
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
31st May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
30th May 2024 | SOU EXTENSION 1 FILED |
30th May 2024 | SOU EXTENSION 1 GRANTED |
30th May 2024 | SOU TEAS EXTENSION RECEIVED |
22nd Feb 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
22nd Feb 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
22nd Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
22nd Feb 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
12th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
17th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |